IMI-2 Ebola and other filoviral haemorrhagic fevers: future outbreaks (Call 8)

Projects that increase the readiness to respond to future outbreaks of Ebola and other filoviral haemorrhagic fevers. 55 MEUR is available. Deadline: September 14th 2017.

Key Project deliverables might include (but are not limited to) the following:

  • the progression of a novel vaccine candidate, diagnostic or treatment up to a stage ready for testing in an outbreak setting.
  • the development of tools to help with pre-clinical and clinical development of vaccine candidates and treatments (incl. Proof of Concept testing of existing platforms for screening compounds for Ebola and other filoviruses).
  • the development and/or validation of a novel diagnostic test that is sufficiently sensitive, rapid, user-friendly, cheap, and usable in resource-limited settings.
  • the development of novel strategies to improve the stability of vaccines against Ebola and other filoviral infections during transport and storage, e.g. which would allow storage at 8°C or ambient temperatures for prolonged durations.
  • the development of novel manufacturing and delivery strategies.
  • the development of learning and strategies for optimal deployment and adherence to vaccination programmes.
  • the facilitation of the exploitation of recent advances in our understanding of Ebola and other filoviral infections and the acceleration of their development into health care interventions.

More information on the IMI Call 08 webpage and on the H2020 Participant Portal.

Published Aug. 2, 2017 4:56 PM - Last modified Aug. 2, 2017 5:16 PM